In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter International Inc.

https://www.baxter.com/

Latest From Baxter International Inc.

Falling At The Start Line: Chinese Firms Face Multiple Commercial Challenges Beyond Price, Coverage

Sales of a global first-in-class dermatology drug that gained its first approval in China are falling well behind those of its overseas counterpart. In this case study, Scrip takes a deep dive into the multiple underlying factors determining success in the world's second-largest pharma market beyond pricing and reimbursement coverage, including complex hospital entry, dual channels and competition considerations. 

China Commercial

Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else

Almost 80% of novel agent submissions from the biggest companies were approved in recent years, compared with a 60% approval rate for the rest of the industry, according to a Pink Sheet analysis of FDA approval decisions since 2021.

US FDA Performance Tracker Drug Review

Deal Watch: Novartis Acquires Gene Therapy Candidate From AvroBio

AvroBio retains rights to its other HSC gene therapy candidates. Alimera Acquires Further Commercial Rights To Eyepoint’s Uveitis Drug.

Deal Watch Business Strategies

Pear Bankruptcy Filing Highlights Difficult Challenges Facing Digital Therapeutics

Pear Therapeutics filed for Chapter 11 bankruptcy in April and sold its remaining assets in an auction for about $6m. The demise of one the pioneers in the prescription digital therapeutics industry highlights the challenges PDT developers face getting their products reimbursed.

Digital Health Business Strategies
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Other Names / Subsidiaries
    • AesRX LLC
    • Althin Medical A.B.
    • Chatham Therapeutics
    • Cheetah Medical
    • Claris Injectables Limited
    • Fusion Medical Technologies, Inc.
    • Gambro AB
    • Immuno-US
    • Prism Pharmaceuticals, Inc.
    • Renal Therapy Services
    • SIGMA International Geneeral Medical Apparatus
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Wound Care Technologies, Inc.
    • Baxter Healthcare Corporation
UsernamePublicRestriction

Register